Literature DB >> 12125914

The effect of cigarette smoking on ceruloplasmin and C3 complement: risk of cardiovascular disease (atherosclerosis).

Rungsunn Tungtrongchitr1, Praneet Pongpaew, Benjaluck Phonrat, Venus Supawan, Somchai Chanjanakitskul, Niyomsri Vudhivai, Frank Peter Schelp.   

Abstract

Serum ceruloplasmin, C3 complement and albumin in 119 male smokers and 65 male non-smoker; from a military unit in Bangkok were investigated in this study. The serum ceruloplasmin concentration was found to be significantly higher in smokers than in non-smokers. However, the serum albumin concentration in smokers was statistically significantly lower than in non-smokers. Significant associations were also found between ages, albumin levels and the quantity of cigarettes smoked. There was a significant positive correlation between serum ceruloplasmin and C3 complement concentrations. An association between the quantity of cigarettes smoked and albumin was also found, as well as a significant relationship between smoking and the quantities of cigarettes smoked to serum ceruloplasmin levels when smoking and the quantity of cigarettes smoked were taken as independent variables, and the serum ceruloplasmin levels as a dependent variable. This might suggest that high concentrations of the acute-phase protein, i.e. ceruloplasmin, might constitute a risk of developing atherosclerosis or cardiovascular disease in smokers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12125914

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  1 in total

1.  Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers.

Authors:  Sunitha Kodidela; Yujie Wang; Benjamin J Patters; Yuqing Gong; Namita Sinha; Sabina Ranjit; Kelli Gerth; Sanjana Haque; Theodore Cory; Carole McArthur; Anil Kumar; Jim Y Wan; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-08       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.